Roopa Industries Ltd Stock Price Today (NSE: ROOPAIND)
Fundamental Score
Roopa Industries Ltd Share Price Live NSE/BSE & Institutional Fundamental Analysis
Roopa Industries Ltd share price today is ₹46.96, up +0.00% on NSE/BSE as of 19 February 2026. Roopa Industries Ltd (ROOPAIND) is a Small-cap company in the Pharmaceuticals sector with a market capitalisation of ₹39.26 (Cr). The 52-week high for ROOPAIND share price is ₹N/A and the 52-week low is ₹N/A. At a P/E ratio of 20.45x, ROOPAIND is currently trading below its industry average P/E of 31.77x. The company has a Return on Equity (ROE) of 12.07% and a debt-to-equity ratio of 1.98.
Roopa Industries Ltd Share Price Chart — NSE/BSE Historical Performance
Returns & Performance
ROE
ROCE
OPM (5Y)
Div Yield
Roopa Industries Ltd Valuation Check
P/E Ratio
Industry P/E
Market Cap
Growth Engine
Profit Growth (Q)
Sales Growth (Q)
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Balance Sheet Health
Debt to Equity
Int. Coverage
Free Cash Flow (5Y)
Shareholding
Promoter
FII
DII
Pledged
Institutional Deep-Dive
Bull Run Research Hub
Roopa Share Price: Financial Stability Analysis
The pharmaceutical industry, known for its inelastic demand and innovation-driven growth, presents a unique landscape for financial analysis. This report examines the financial stability of Roopa Industries Ltd, focusing on its current standing and competitive positioning. Currently, the Roopa share price stands at ₹49.0, with a Price-to-Earnings (PE) ratio of 20.45 and a Return on Capital Employed (ROCE) of 11.96%. We will analyze these metrics in relation to its peers to assess its financial health.
A crucial element in evaluating any company's potential is its profitability compared to its peers. Roopa Industries operates in a sector alongside companies like Mankind Pharma Ltd, Smruthi Organics Ltd, and Balaxi Pharmaceuticals Ltd. While a detailed comparison requires a deeper dive into their respective financials, it is imperative to note that the quality of management teams can greatly impact operational efficiency. Examining
Mankind Pharma Ltd, for example, provides a valuable comparative benchmark in terms of corporate governance and strategic decision-making which ultimately influences shareholder value.The 11.96% ROCE of Roopa Industries is a significant indicator of how effectively the company is using its capital to generate profits. ROCE is a great indicator of economic moats. A consistent ROCE above the cost of capital suggests a competitive advantage. However, in the long run, a higher ROCE translates to greater efficiency, which can lead to a stronger moat, attracting further investment and potentially improving Roopa's financial stability.
This analysis forms part of a comprehensive 80-parameter fundamental audit, verified by Sweta Mishra, to assess Roopa Industries' financial health. This analysis is for informational purposes only and focuses on observational data. No buy or sell recommendations are being made.
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Roopa Industries Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of ROOPAIND across key market metrics for learning purposes.
Positive Indicators
5 factors identified
Attractive Valuation (P/E: 20.45 vs Industry: 31.77)
Observation: Trading at discount to industry peers.
Analysis: P/E below industry average may present value opportunity.
Consistent Growth Track Record (34.28% CAGR)
Observation: Strong 5-year sales compound annual growth rate.
Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model.
Excellent EPS Growth (40.00% CAGR)
Observation: Outstanding 5-year earnings per share compound growth.
Analysis: EPS CAGR >15% indicates strong wealth creation potential.
Strong Profit Growth Track Record (40.00% CAGR)
Observation: Consistent 5-year profit compound annual growth rate.
Analysis: Profit CAGR >15% demonstrates scalable business model.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
6 factors identified
Profit Decline Concern (-20.69%)
Observation: Significant year-over-year profit contraction observed.
Analysis: Declining profitability requires investigation into underlying causes.
Elevated Debt Levels (D/E: 1.98)
Observation: High leverage increases financial risk and interest burden.
Analysis: High debt-to-equity ratios require monitoring of debt servicing capability.
Weak Interest Coverage (1.88x)
Observation: Limited ability to service debt obligations from earnings.
Analysis: Low interest coverage raises concerns about financial stability.
Negative Free Cash Flow (₹-5.59 Cr over 5Y)
Observation: Cash outflows exceed inflows.
Analysis: Negative FCF requires analysis of capital expenditure cycle.
Limited Institutional Interest (FII+DII: 0.25%)
Observation: Low institutional participation may affect liquidity.
Analysis: Limited institutional interest may indicate size constraints or visibility issues.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Roopa Industries Ltd Financial Statements
Comprehensive financial data for Roopa Industries Ltd including income statement, balance sheet and cash flow
About ROOPAIND (Roopa Industries Ltd)
Roopa Industries Ltd (ROOPAIND) is listed on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) of India. The company operates in the Pharmaceuticals sector with a current market capitalisation of ₹39.26 (Cr). Roopa Industries Ltd has delivered a Return on Equity (ROE) of 12.07% and a ROCE of 11.96%. The debt-to-equity ratio stands at 1.98, reflecting the company's capital structure. Investors tracking ROOPAIND share price can monitor key metrics including P/E ratio, promoter holding of 48.03%, and quarterly earnings growth.
Company Details
Key Leadership
ROOPAIND Share Price: Frequently Asked Questions
What is the current share price of Roopa Industries Ltd (ROOPAIND)?
As of 19 Feb 2026, 10:19 am IST, Roopa Industries Ltd share price is ₹46.96. The ROOPAIND stock has a market capitalisation of ₹39.26 (Cr) on NSE/BSE.
Is ROOPAIND share price Overvalued or Undervalued?
ROOPAIND share price is currently trading at a P/E ratio of 20.45x, compared to the industry average of 31.77x. Based on this relative valuation, the Roopa Industries Ltd stock appears to be Undervalued against its sector peers.
What is the 52-week high and low of ROOPAIND share price?
The 52-week high of ROOPAIND share price is ₹N/A and the 52-week low is ₹N/A.
What factors affect the Roopa Industries Ltd share price?
Key factors influencing ROOPAIND share price include quarterly earnings growth (Sales Growth: 12.22%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is Roopa Industries Ltd a good stock for long-term investment?
Roopa Industries Ltd shows a 5-year Profit Growth of 40.00% and an ROE of 12.07%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 1.98 before investing in ROOPAIND shares.
How does Roopa Industries Ltd compare with its industry peers?
Roopa Industries Ltd competes with major peers in the Pharmaceuticals. Investors should compare ROOPAIND share price P/E of 20.45x and ROE of 12.07% against the industry averages to determine competitive standing.
What is the P/E ratio of ROOPAIND and what does it mean?
ROOPAIND share price has a P/E ratio of 20.45x compared to the industry average of 31.77x. Investors pay ₹20 for every ₹1 of annual earnings.
How is ROOPAIND performing according to Bull Run's analysis?
ROOPAIND has a Bull Run fundamental score of 47.8/100, indicating concerns requiring careful analysis. This comprehensive rating is based on 15+ financial parameters.
What sector and industry does ROOPAIND belong to?
ROOPAIND operates in the Pharmaceuticals industry. This classification helps understand the competitive landscape and sector-specific trends affecting Roopa Industries Ltd share price.
What is Return on Equity (ROE) and why is it important for ROOPAIND?
ROOPAIND has an ROE of 12.07%, which shows decent profitability but room for improvement. ROE measures how efficiently Roopa Industries Ltd generates profits from shareholders capital.
How is ROOPAIND debt-to-equity ratio and what does it indicate?
ROOPAIND has a debt-to-equity ratio of 1.98, which indicates high leverage that increases financial risk.
What is ROOPAIND dividend yield and is it a good dividend stock?
ROOPAIND offers a dividend yield of 0.00%, meaning you receive ₹0.00 annual dividend for every ₹100 invested in Roopa Industries Ltd shares.
How has ROOPAIND share price grown over the past 5 years?
ROOPAIND has achieved 5-year growth rates of: Sales Growth 34.28%, Profit Growth 40.00%, and EPS Growth 40.00%.
What is the promoter holding in ROOPAIND and why does it matter?
Promoters hold 48.03% of ROOPAIND shares, with 0.00% pledged. High promoter holding often indicates strong management confidence in Roopa Industries Ltd.
What is ROOPAIND market capitalisation category?
ROOPAIND has a market capitalisation of ₹39 crores, placing it in the Small-cap category.
How volatile is ROOPAIND stock?
ROOPAIND has a beta of N/A. A beta > 1 suggests the Roopa Industries Ltd stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is ROOPAIND operating profit margin trend?
ROOPAIND has a 5-year average Operating Profit Margin (OPM) of 5.36%, indicating the company's operational efficiency.
How is ROOPAIND quarterly performance?
Recent quarterly performance shows Roopa Industries Ltd YoY Sales Growth of 12.22% and YoY Profit Growth of -20.69%.
What is the institutional holding pattern in ROOPAIND?
ROOPAIND has FII holding of 0.25% and DII holding of 0.00%. Significant institutional holding often suggests professional confidence in the Roopa Industries Ltd stock.